Dr Florence TubachRhumatologue à Paris 13e

2026Cell metabolismPubMed

Immunometabolic endotypes define distinct clinical trajectories in type 2 diabetes

2026Journal of neurology, neurosurgery, and psychiatryPubMed

Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study

2026Nature medicinePubMed

COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer

2026Parkinsonism & related disordersPubMed

Motor complications and postural abnormalities interplay in Parkinson's disease

2025CNS drugsPubMed

Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK Cohort

2025The Lancet. Infectious diseasesPubMed

Mycoplasma pneumoniae infection in adult inpatients during the 2023-24 outbreak in France (MYCADO): a national, retrospective, observational study

2025NeurologyPubMed

Recurrence and Mortality After a First Status Epilepticus: A Retrospective Nationwide Study From the French National Health Data System

2025Fundamental & clinical pharmacologyPubMed

Use and misuse of domperidone in patients living with Parkinson disease in France

2024The European journal of general practicePubMed

Appropriateness of intended antibiotic prescribing using clinical case vignettes in primary care, and related factors

2024Journal of thrombosis and haemostasis : JTHPubMed

Sensitivity and specificity of strategies to identify patients with hemostasis abnormalities leading to an increased risk of bleeding before scheduled intervention: the Hemorisk study

2024TherapiePubMed

[Evaluation of the satisfaction of healthcare professionals using the CRAT website, and launch of a new version]

2024Journal of neural transmission (Vienna, Austria : 1996)PubMed

Amantadine use in the French prospective NS-Park cohort

2024Clinics and research in hepatology and gastroenterologyPubMed

Association between direct acting agents used for chronic hepatitis C virus infection and the occurrence of acute leukaemia - A disproportionality analysis

2024Nature medicinePubMed

Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

2023Nature medicinePubMed

Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

2023Nature medicinePubMed

Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis

2026Journal of epidemiology and population healthPubMed

Algorithms for the identification of ophthalmic diseases in medico-administrative databases: A systematic review

2026European heart journalPubMed

Incidence and risk factors of immune checkpoint inhibitor myocardial and muscle toxicity: a French nationwide study

2026Joint bone spinePubMed

Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: A population-based cohort study

2025Diabetes & metabolismPubMed

Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort

2026Journal of epidemiology and population healthPubMed

Algorithms for the identification of ophthalmic diseases in medico-administrative databases: A systematic review

2024European journal of epidemiologyPubMed

Risk of congenital malformations and miscarriages following maternal use of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis

2024BMJ openPubMed

Conducting observational analyses with the target trial emulation approach: a methodological systematic review

2024TherapiePubMed

Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase

2026Journal of epidemiology and population healthPubMed

Algorithms for the identification of ophthalmic diseases in medico-administrative databases: A systematic review

2024European journal of epidemiologyPubMed

Risk of congenital malformations and miscarriages following maternal use of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis

2024BMJ openPubMed

Conducting observational analyses with the target trial emulation approach: a methodological systematic review

2024TherapiePubMed

Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase

2026Journal of autoimmunityPubMed

Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data

2025Rheumatology (Oxford, England)PubMed

Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients

2025The Lancet regional health. EuropePubMed

Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study

2026European heart journalPubMed

Incidence and risk factors of immune checkpoint inhibitor myocardial and muscle toxicity: a French nationwide study

2025EClinicalMedicinePubMed

Long-term safety of mid-urethral sling for stress urinary incontinence in women: an emulated trial using French national health data system

2024Journal of clinical epidemiologyPubMed

A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness

2026JAMA network openPubMed

Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis

2026European journal of preventive cardiologyPubMed

Cardiovascular risk among Giant cells arteritis patients

2025Archives of cardiovascular diseasesPubMed

Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design

2025Archives of cardiovascular diseasesPubMed

Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2026Clinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPubMed

Recombinant vs Standard Influenza Vaccine in Adults With Severe Obesity: A Randomized Clinical Trial

2026JAMAPubMed

Levosimendan to Facilitate Weaning From ECMO in Patients With Severe Cardiogenic Shock: The LEVOECMO Randomized Clinical Trial

2026RMD openPubMed

Glucocorticoid in giant cell arteritis: real-world treatment patterns over time and associated burden in a nationwide hospital-based study within the French health insurance database

2026JAMA network openPubMed

Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis

2024Arthritis & rheumatology (Hoboken, N.J.)PubMed

Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

2023The Lancet regional health. EuropePubMed

Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study

2024European journal of emergency medicine : official journal of the European Society for Emergency MedicinePubMed

Biomarkers of COVID-19 short-term worsening: a multiparameter analysis within the prospective multicenter COVIDeF cohort

2026Journal of the European Academy of Dermatology and Venereology : JEADVPubMed

Impact of methotrexate administration route on drug survival in psoriasis: Results from PSOBIOTEQ

2024Journal of neurologyPubMed

Burden of status epilepticus: prognosis and cost driving factors, insight from a nationwide retrospective cohort study of the French health insurance database

2024Genome medicinePubMed

Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

2025NPJ biofilms and microbiomesPubMed

Gut microbiota alterations are linked to COVID-19 severity in North African and European populations

2024EpilepsiaPubMed

Benzodiazepines for pediatric epilepsies and their risks in a cohort within the French health care data

2024Journal of clinical epidemiologyPubMed

A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness

2017 · doctorant : David Hajage

Utilisation du score de propension et du score pronostique en pharmacoépidémiologie

2016 · doctorant : Stéphane Gaudry

Critères de jugement dans les essais contrôlés randomisés en réanimation

2013 · doctorant : Candice Poels-Estellat

Choix du traitement comparateur dans les essais contrôlés randomisés